» Articles » PMID: 16449530

Cytokine Polymorphisms in the Th1/Th2 Pathway and Susceptibility to Non-Hodgkin Lymphoma

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2006 Feb 2
PMID 16449530
Citations 81
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have demonstrated that common polymorphisms in Th1 and Th2 cytokine genes can alter gene expression, modulate the balance between Th1/Th2 responsiveness, and influence susceptibility for autoimmune disorders, infectious diseases, and cancer. We analyzed one or more single nucleotide polymorphisms (SNPs) in 20 candidate Th1/Th2 genes in a population-based case-control study of non-Hodgkin lymphoma (NHL; n = 518 cases, 597 controls) among women in Connecticut. SNPs in critical genes, IL4, IL5, IL6, and IL10, were associated with risk for NHL and in some instances with a specific histologic subtype. Analysis of 4 SNPs in the IL10 promoter (-3575T>A, -1082A>G, -819C>T, and -592C>A) revealed that both the AGCC haplotype (odds ratio [OR] = 1.54, 95% confidence interval [CI] = 1.21-1.96, P < .001) and the TATA haplotype (OR = 1.37, 95% CI = 1.05-1.79, P = .02) were associated with increased risk for B-cell lymphomas. In contrast, the IL4-1098G allele was associated with increased risk of T-cell lymphomas (OR = 3.84; 95% CI = 1.79-8.22; P < .001). Further, the IL10 and IL4 SNP associations remained significant after adjusting for multiple comparisons. These results suggest that SNPs in Th2 cytokine genes may be associated with risk of NHL.

Citing Articles

An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis.

Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Borrelli A Int J Mol Sci. 2024; 25(16).

PMID: 39201794 PMC: 11354457. DOI: 10.3390/ijms25169108.


Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Cai L, Du X, Zhang C, Yu S, Liu L, Zhao J Cancer Immunol Immunother. 2021; 71(7):1597-1609.

PMID: 34731284 PMC: 9188536. DOI: 10.1007/s00262-021-03095-z.


Statistical meta-analysis to investigate the association between the Interleukin-6 (IL-6) gene polymorphisms and cancer risk.

Harun-Or-Roshid M, Ali M, Jesmin , Haque Mollah M PLoS One. 2021; 16(3):e0247055.

PMID: 33684135 PMC: 7939379. DOI: 10.1371/journal.pone.0247055.


The effect of LTA gene polymorphisms on cancer risk: an updated systematic review and meta- analysis.

Li J, Wang Y, Chang X, Han Z Biosci Rep. 2020; 40(5).

PMID: 32420584 PMC: 7256675. DOI: 10.1042/BSR20192320.


The Impact of IL-6 and IL-10 Gene Polymorphisms in Diffuse Large B-Cell Lymphoma Risk and Overall Survival in an Arab Population: A Case-Control Study.

Al-Khatib S, Abdo N, Al-Eitan L, Al-Mistarehi A, Zahran D, Kewan T Cancers (Basel). 2020; 12(2).

PMID: 32046104 PMC: 7072608. DOI: 10.3390/cancers12020382.


References
1.
Chiu B, Weisenburger D . An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma. 2004; 4(3):161-8. DOI: 10.3816/clm.2003.n.025. View

2.
Kruse S, Japha T, Tedner M, Sparholt S, Forster J, Kuehr J . The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology. 1999; 96(3):365-71. PMC: 2326760. DOI: 10.1046/j.1365-2567.1999.00705.x. View

3.
Gibson A, Edberg J, Wu J, Westendorp R, Huizinga T, Kimberly R . Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol. 2001; 166(6):3915-22. DOI: 10.4049/jimmunol.166.6.3915. View

4.
Moore K, de Waal Malefyt R, Coffman R, OGarra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765. DOI: 10.1146/annurev.immunol.19.1.683. View

5.
Hackstein H, Hecker M, Kruse S, Bohnert A, Ober C, Deichmann K . A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics. 2001; 53(4):264-9. DOI: 10.1007/s002510100324. View